Abstract
Background: The study investigates the prognostic significance of lymph node ratio (LNR) on patients with head and neck squamous cell carcinoma (HNSCC) with coexistence of multiple adverse pathological features. Methods: In total, 100 patients with coexistence of perineural invasion, lymphovascular invasion, and extranodal extension of first primary HNSCC treated with radical surgery followed by adjuvant chemoradiotherapy were enrolled. Results: The optimal LNR cut-off value for predicting overall survival (OS) and cancer specific survival (CSS) was 7%. In Cox model, we observed that LNR ≥7% was a statistically significant unfavorable predictor of OS (HR: 2.689; 95% CI: 1.228–5.889; p = 0.013) and CSS (HR: 3.162; 95% CI: 1.234–8.102; p = 0.016). Conclusion: For HNSCC patients with coexistence of multiple adverse pathological features, LNR is an independent survival predictor. Novel intensified treatments are needed for the subgroup of patients with a high LNR.
| Original language | English |
|---|---|
| Pages (from-to) | 2017-2027 |
| Number of pages | 11 |
| Journal | Head and Neck |
| Volume | 45 |
| Issue number | 8 |
| DOIs | |
| State | Published - 08 2023 |
| Externally published | Yes |
Bibliographical note
© 2023 Wiley Periodicals LLC.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- extranodal extension
- head and neck squamous cell carcinoma
- lymph node ratio
- lymphovascular invasion
- perineural invasion
- Prognosis
- Humans
- Head and Neck Neoplasms/therapy
- Carcinoma, Squamous Cell/pathology
- Lymph Nodes/pathology
- Retrospective Studies
- Squamous Cell Carcinoma of Head and Neck/therapy
- Neoplasm Staging
- Lymph Node Ratio
Fingerprint
Dive into the research topics of 'Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver